Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma
Sponsor: Tanta University
Summary
Complementary and adjunctive therapies are increasingly being explored to enhance asthma control and reduce airway inflammation. Nigella sativa (black seed) is a medicinal plant used traditionally in multiple regions and has demonstrated anti-inflammatory, immunomodulatory, and bronchodilator effects. Its potential as an adjuvant therapy in asthma has attracted attention in both preclinical and clinical research
Key Details
Gender
All
Age Range
6 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-01-01
Completion Date
2026-10-31
Last Updated
2026-01-02
Healthy Volunteers
No
Conditions
Interventions
Nigella sativa Oil Capsules (100 mg/kg/day)
Nigella sativa oil administered orally in capsule form at a dose of 100 mg/kg/day as adjunct therapy.
Nigella sativa Oil Capsules (50 mg/kg/day)
Nigella sativa oil administered orally in capsule form at a dose of 50 mg/kg/day as adjunct therapy.
Fluticasone / Long-Acting Beta-2 Agonist Combination
Low-dose inhaled corticosteroid (fluticasone propionate 200 µg/day) combined with a long-acting beta-2 agonist (two puffs every 12 hours), administered via metered-dose inhaler with spacer.